About Dash Pharmaceuticals
Developer of advanced spectroscopic and laser-based instrumentation. It designs and manufactures spectrometers and laser systems for various industrial applications, including nuclear decommissioning, high-value manufacturing, pharmaceuticals, and biopharmaceuticals. The companys technology, originally developed for space applications, enables highly sensitive measurement and identification of substances in challenging environments. Its offerings include Raman spectrometers, miniature spectrometers, and bespoke LIDAR solutions. It also provides in-house sampling services and expertise in FabryPérot interferometry. The firm collaborates with industry and academia to develop innovative solutions for complex analytical challenges.
- Headquarter Upper Saddle River, United States
- Founders Julie Trendowicz, David Rosen, Nick DiMaio
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Natco Pharma
(Dec 14, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Dash Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Dash Pharmaceuticals
Dash Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Natco Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
APIs and finished dosage forms are developed and manufactured.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Dash Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Dash Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Dash Pharmaceuticals Comparisons
Competitors of Dash Pharmaceuticals
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Dash Pharmaceuticals
When was Dash Pharmaceuticals founded?
Dash Pharmaceuticals was founded in 2014.
Where is Dash Pharmaceuticals located?
Dash Pharmaceuticals is headquartered in Upper Saddle River, United States. It is registered at Upper Saddle River, New Jersey, United States.
Who is the current CEO of Dash Pharmaceuticals?
David Rosen is the current CEO of Dash Pharmaceuticals. They have also founded this company.
What does Dash Pharmaceuticals do?
Developer of advanced spectroscopic and laser-based instrumentation. It designs and manufactures spectrometers and laser systems for various industrial applications, including nuclear decommissioning, high-value manufacturing, pharmaceuticals, and biopharmaceuticals. The companys technology, originally developed for space applications, enables highly sensitive measurement and identification of substances in challenging environments. Its offerings include Raman spectrometers, miniature spectrometers, and bespoke LIDAR solutions. It also provides in-house sampling services and expertise in FabryPérot interferometry. The firm collaborates with industry and academia to develop innovative solutions for complex analytical challenges.
Who are Dash Pharmaceuticals's investors?
Dash Pharmaceuticals has 1 investor. Key investors include Natco Pharma.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.